Self-reported psychopathology and health-related quality of life in heroin users treated with methadone

Neuropsychiatric Disease and Treatment

Volumn 9, Issue 1, 2012, Pages 41-48

  Chen, Ying Zai ^a   Huang, Wei Lieh ^a,b   Shan, Jia Chi ^a,c   Lin, Yu Hsuan ^a,b   Chang, Hung Chieh Wu ^a   Chang, Li Ren ^a,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

BriefSymptom rating scale; Heroin abuse; World health organization questionnaire on quality of life

Indexed keywords

METHADONE;

ADULT; ALCOHOL CONSUMPTION; ANOREXIA; ANXIETY; ARTICLE; BRIEF SYMPTOM INVENTORY; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DSM-IV; FEMALE; HEALTH STATUS; HEROIN DEPENDENCE; HUMAN; INFORMED CONSENT; MALE; MENTAL DISEASE; PARANOIA; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SLEEP DISORDER; SYMPTOM CHECKLIST 90; TAIWAN; VISUAL ANALOG SCALE; WORLD HEALTH ORGANIZATION;

EID: 84872090213     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S37284     Document Type: Article

References (36)

1. Chang LR, Lin YH, Kuo TB, et al. Cardiac autonomic modulation during methadone therapy among heroin users: a pilot study. Prog Neuropsy-chopharmacol Biol Psychiatry. 2012;37:188-193.
2. McLellan AT, Lewis DC, O'Brien C P, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689-1695.
3. Millson PE, Challacombe L, Villeneuve PJ, et al. Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Can J Public Health. 2004;95:99-103.
4. Huang WL, Lin YH, Kuo TB, Chang LR, Chen YZ, Yang CC. Methadone-mediated autonomic functioning of male patients with heroin dependence: the influence of borderline personality pattern. PLoS One. 2012;7:e37464.
5. Carpentier PJ, Krabbe P F, van Gogh MT, Knapen LJ, Buitelaar JK, de Jong CA. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18:470-480.
6. Reimer J, Verthein U, Karow A, Schafer I, Naber D, Haasen C. Physical and mental health in severe opioid-dependent patients within a randomised controlled maintenance treatment trial. Addiction. 2011; 106:1647-1655.
7. Schwartz R P, Highfield DA, Jaffe JH, et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry. 2006;63: 102-109.
8. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515-532.
9. Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction. 2008;103:462-468.
10. Pedro Ruiz ECS. Substance Abuse: A Comprehensive Textbook. 5th ed. Philidelphia, PA: Lippincott Williams & Wilkins; 2011.
11. Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J Consult Clin Psychol. 1992;60:927-934.
12. King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model. J Subst Abuse Treat. 2006;31:385-393.
13. Winstock AR, Lea T, Sheridan J. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. Int J Drug Policy. 2008;19:450-458.
14. Karow A, Verthein U, Pukrop R, et al. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence. Subst Use Misuse. 2011;46: 705-715.
15. Gonzalez-Saiz F, Rojas OL, Castillo II. Measuring the impact of psy-choactive substance on health-related quality of life: an update. Curr Drug Abuse Rev. 2009;2:5-10.
16. Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord. 2007;99:213-220.
17. Lasalvia A, Ruggeri M, Santolini N. Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6. Psychother Psychosom. 2002;71: 275-284.
18. Yen CN, Wang CS, Wang TY, Chen HF, Chang HC. Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci. 2011;27:177-183.
19. Derogatis LR. Rickels K RA. The SCL-90 and the MMPI:a step in the validation of a new self-report scale. The British Journal of Psychiatry. 1976;128:280-289.
20. Lee MB, Lee YJ, Yen LL, Lin MH, Lue BH. Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in clinical practice. J Formos Med Assoc. 1990;89:1081-1087.
21. Chen CA, Liao SC, Wang JK, et al. Quality of life in adults with congenital heart disease: biopsychosocial determinants and sex-related differences. Heart. 2011;97:38-43.
22. Group TW. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-558.
23. Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc. 2002;101:342-351.
24. Chang LR, Lin YH, Kuo TB, et al. Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management. PLoS One. 2011;6:e26378.
25. Chang TJ, Tarn YH, Hsieh CL, Liou WS, Shaw JW, Chiou XG. Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J Formos Med Assoc. 2007;106:1023-1031.
26. Grau LE, Green TC, Torban M, et al. Psychosocial and contextual correlates of opioid overdose risk among drug users in St Petersburg, Russia. Harm Reduct J. 2009;6:17.
27. Walter D, Nagoshi C, Muntaner C, Haertzen CA. The prediction of drug dependence from expectancy for hostility while intoxicated. Int J Addict. 1990;25:1151-1168.
28. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien C P. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953-1959.
29. Kanof PD, Aronson MJ, Ness R. Organic mood syndrome associated with detoxifcation from methadone maintenance. Am J Psychiatry. 1993;150:423-428.
30. Stein MD, Kurth ME, Sharkey KM, Anderson BJ, Corso R P, Millman R P. Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial. Drug Alcohol Depend. 2012;120:65-73.
31. Franco OH, Wong YL, Kandala NB, et al. Cross-cultural comparison of correlates of quality of life and health status: the Whitehall II Study (UK) and the Western New York Health Study (US). Eur J Epidemiol. 2012;27:255-265.
32. Stranges S, Dorn JM, Shipley MJ, et al. Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study. Am J Epidemiol. 2008;168:1353-1364.
33. Lejuez C W, Paulson A, Daughters SB, Bornovalova MA, Zvolensky MJ. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Behav Res Ther. 2006;44:667-677.
34. Frischknecht U, Beckmann B, Heinrich M, et al. The vicious circle of perceived stigmatization, depressiveness, anxiety, and low quality of life in substituted heroin addicts. Eur Addict Res. 2011;17:241-249.
35. Jacobs PE, Doft EB, Koger J. A study of SCL-90 scores of 264 metha-done patients in treatment. Int J Addict. 1981;16:541-548.
36. Wu LT, Ling W, Burchett B, Blazer DG, Shostak J, Woody GE. Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxifcation: results from the National Drug Abuse Treatment Clinical Trials Network. Subst Abuse Rehabil. 2010:13-22.